Introduction Implementing the ICH Q6B Guidelines for Biological Characterisation requires a comprehensive, multi-orthogonal analytical strategy to verify that a proposed […]
Introduction: Matrix effects in LC-MS/MS bioanalysis are among the most significant challenges affecting the reliability of pharmacokinetic, toxicokinetic, and therapeutic
Matrix Effects in LC-MS/MS Bioanalysis: Causes, Detection, and Mitigation Strategies Read More »
Introduction: Peptide therapeutics are one of the fastest-growing drug classes in the pharmaceutical pipeline, but their structural complexity demands rigorous
Introduction Obtain regulatory approval for IND, NDA, and BLA submissions with the support of professional Extractables & Leachables (E&L) Consulting
Introduction: PLGA for pulmonary drug delivery has become a focal point for formulators seeking to extend the therapeutic window of
Introduction Cell-Penetrating Peptides in Oligonucleotide Conjugates are sophisticated chimeric macromolecules developed to address the significant challenge of poor cellular uptake
Introduction Characterization Methods for PLGA Microspheres involve a comprehensive range of advanced analytical techniques used to assess the physicochemical properties,
Introduction Nitrosamine Control Strategy Development Services offer a comprehensive, science-driven framework for identifying, quantifying, and controlling mutagenic N-nitroso impurities throughout
Introduction Metabolite quantification in bioanalysis plays an essential role throughout the drug development process by providing a definitive assessment of
Metabolite Quantification in Bioanalysis: When Is It Required and How Is It Validated? Read More »
Introduction Stability testing in bioanalysis, as outlined in the ICH M10 guideline, provides scientific evidence that every stage of sample
